Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India

doi:10.3748/wjg.v19.i48.9294

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8285)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

419

HTML

4835

Figures (1-3)

281

Tables (1-3)

215

Sum=5750

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1227

Download

1308

Sum=2535

Dec 28, 2013 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2013; 19(48): 9294-9306
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9294

Table 1 Demographic, clinical and virological characteristics of hepatitis B surface antigen-positive patients with different disease profiles

	Characteristic	Group I HCC (n = 44)	Group II CR (n = 22)	Group III CH (n = 25)	Total (n = 91)
Demographic and clinical data	Gender (M/F)	33/11	18/4	18/7	69/22
	Age (yr) (mean ± SD)	48.70 ± 10.94^a	40.68 ± 11.52	26.28 ± 11.10	40.87 ± 14.66
	ALT, IU/L	73.50 ± 11.65	70.50 ± 41.09	56.32 ± 30.01	67.45 ± 37.74
	HBeAg positive¹	7 (24.14)	4 (14.3)	9 (37.5)	20 (26.67)
Virological characteristics	HBV DNA log₁₀ copies/mL¹	4.79 ± 1.41^a	3.38 ± 1.69	3.27 ± 2.12	4.03 ± 1.83
	Number genotyped by direct sequencing/RFLP	21/19	9/12	19/6	86
	Genotype A	33 (82.5)^a	14 (66.6)	15 (60)	62 (72.1)
	Subgenotype A1	30	14	15	59 (95)
	Subgenotype A2	3	-	-	3 (5)
	Genotype C	-	1 (4.8)	-	1 (1.2)
	Genotype D	7 (17.5)	6 (28.6)	10 (40)	23 (26.7)
	Subgenotype D1²	-	1	3
	Subgenotype D2	4	2	6
	Subgenotype D3	1	-	-

^aP < 0.05 vs chronic hepatitis.

¹Depletion of serum allowed the viral loads to be determined for only 28, and hepatitis B e antigen for 29 HCC sera;

²Subgenotyping of genotype D was performed by direct sequencing. CH: Chronic hepatitis; HCC: Hepatocellular carcinoma; CR: Cirrhosis; SD: Standard deviation; ALT: Alanine aminotransferase; RFLP: Restriction fragment length polymorphism; HBeAg: Hepatitis B e antigen.

Table 2 Multiple logistic regression analysis of basal core promoter/precore region in different disease groups

		HCC		Non HCC (CR/CH)		OR (95%CI)	P value
		Gen A (n = 20)	Gen D (n = 6)	Gen A (n = 26)	Gen D (n = 11)
Basic core promoter/ pre core region	A1762T/G1764A + G1764A only	16 (80)	5 (83)	14 (54)	3 (27)	20.2 (6.3-65)^a	0.008^aNS^d
	C1766T/T1768A	9 (45)	1 (5)	5 (25)	0	25 (7.3-86)^a 14.3 (1.7–119)^d	0.03^a0.05^d
	1773T (genotype A)	19 (95)	-	25	-
	1773C (genotype D)	-	4	-	7	-	NS^a
	G1862T	18 (90)	2 (33)	21 (81)	1(9)	30.33 (5.62-192.6)^d	NS^a 0.0001^d
	G1896A	0	4 (67)	0	2 (18)	-	NS^a 0.0002^c
	A1762T/G1764A + G1862T	13 (65)	1 (2)	13 (50)	0	4.81 (0.6-39.4)^b	NS^a 0.0004^b
Complete S region	Pre-S deletions	5 (33.3)^e	0	3 (17.6)	1 (9)	1.89 (0.54-6.60)^b	NS^bNS^d

^aComparison between hepatocellular carcinoma (HCC) and non-HCC, all genotypes;

^bComparison between HCC and non-HCC, restricted to genotype A isolates;

^cComparison between HCC and non-HCC, restricted to genotype D isolates;

^dComparison between genotype A and D isolates;

^ePercentage out of 15 genotype A HCC isolates that were sequenced in the S region. CR: Cirrhosis; CH: Chronic hepatitis.

Table 3 Summary of the pre-S mutations prevalent among the three clinical groups and genotypes

Isolate	Age/sex	Clinicalstatus	Subgenotype	PreS1	PreS2					Functionsaffected
				Start codon	Nucleotide from the EcoRI start			Amino acids from preS2 start codon
					Start codon	Deletion size	Position	Deletion size	Position
CHB42	40/M	CH	A1	ATG	ACG	-	-	-	-		A
HCC12	60/M	HCC	A1	ATG	ACG	-	-	-	-	A
HCC25	50/M	HCC	A1	ATG	ACG	-	-	-	-	A
CHB137	16/F	CH	A1	Deletion	ATG	18	2854-2871	6	1-6	I
CHB170	29/F	CH	D2	ATG	ATG	21	35-55	7	16-22	T, B, P
CHB202	33/M	CH	A1	ATG	ATG	24	28-51	8	13-21	T, B, P
CHB413	35/M	CH	A1	ATG	ATG	6	49-54	2	21-22	B, P
HCC29	50/F	HCC	A1	ATG	ATA	33	22-54	11	11-22	A, T, B, P
HCC30	32/M	HCC	A1	ATG	ATG	24	30-53	8	13-21	T, B, P
HCC37	30/F	HCC	A1	ATG	ATG	33	24-56	11	11-22	T, B, P
HCC39	55/M	HCC	A1	ATG	ATG	33	24-56	11	11-22	T, B, P
HCCT3	38/M	HCC	A1	ATG	ATA	54	1-54	18	4-22	A, T, B, P, M

A: PreS2 initiation codon abolished; M1T, M1I; I: PreS1 initiation start codon abolished; M: Morphogenesis domain ps1:103-119 and ps2: 1-4; T: T cell epitope ps1: 109-119/ps2: 1-13; B: B cell epitope, amino acids 14-26; P: Putative neutralizing anti-preS2 antibody, amino acids 1-26; HCC: Hepatocellular carcinoma; CHB: Chronic hepatitis B.

Citation: Gopalakrishnan D, Keyter M, Shenoy KT, Leena KB, Thayumanavan L, Thomas V, Vinayakumar K, Panackel C, Korah AT, Nair R, Kramvis A. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India. World J Gastroenterol 2013; 19(48): 9294-9306
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9294.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9294